title: AIDS group takes aim at pharmaceutical firm's patents, prices.
mesh_terms: D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States